B
TECH icon

Bailard’s Bio-Techne TECH Stock Holding History

Bailard’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,900
Closed -$924K – 812
2024
Q2 		$924K Buy
+12,900
New +$949K 0.03% 307

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bailard's TECH Position: Q3 2024 in Review

Bailard sold out of Bio-Techne (TECH) in Q3 2024, closing a stake of 12,900 shares — an estimated $924K sold.

Bailard first reported a position in TECH in Q2 2024 and held it in 1 quarter. The position peaked at $924K in Q2 2024. 561 funds tracked by Wall St. Rank hold TECH as of Q3 2024.

  • Bailard reported no remaining Bio-Techne position as of Q3 2024 after selling out during the quarter.
  • Bailard sold 12,900 Bio-Techne shares in Q3 2024, an estimated $924K.
  • Bailard first reported a position in Bio-Techne in Q2 2024 and held it in 1 quarter.
  • Bailard's Bio-Techne position peaked at $924K in Q2 2024.
  • 561 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2024.

Based on Bailard's 13F filing for Q3 2024, filed 30 Oct 2024.